Trait centric view

1. Trait name:	Residual feed intake
   Ontology terms:	VT:0011164, CMO:0001315

   81 genes are associated with this trait, with QTL/association found

   • ACAD11: Acyl-CoA dehydrogenase family, member 11
     evidenced by: QTL:28494;
   • ACTB: Actin beta
     evidenced by: QTL:296874;
   • ANXA2: Annexin A2
     evidenced by: QTL:153989;
   • AOX1: Aldehyde oxidase 1
     evidenced by: QTL:28499;
   • APIP: APAF1 interacting protein
     evidenced by: QTL:28507;
   • ARHGAP35: Rho GTPase activating protein 35
     evidenced by: QTL:14667;
   • ASNSD1: Asparagine synthetase domain containing 1
     evidenced by: QTL:28497;
   • ATP5F1A: ATP synthase F1 subunit alpha
     evidenced by: QTL:296868; QTL:296869; QTL:296870; QTL:296871;
   • ATP6V0D2: ATPase H+ transporting V0 subunit d2
     evidenced by: QTL:296847;
   • ATP6V1C2: ATPase H+ transporting V1 subunit C2
     evidenced by: QTL:296823;
   • BIN1: Bridging integrator 1
     evidenced by: QTL:28496;
   • CACNA1G: Calcium channel, voltage-dependent, T type, alpha 1G subunit
     evidenced by: QTL:154011; QTL:154012; QTL:25119;
   • CAPN14: Calpain 14
     evidenced by: QTL:296821; QTL:296822;
   • CAST: Calpastatin
     evidenced by: QTL:153976; QTL:153977; QTL:153978; QTL:153979; QTL:153983; QTL:153984; QTL:28504; QTL:28505;
   • CCKBR: Cholecystokinin B receptor
     evidenced by: QTL:24263; QTL:24264; QTL:24272; QTL:24275; QTL:24277;
   • CCSER1: Family with sequence similarity 190, member A
     evidenced by: QTL:154048; QTL:154049;
   • CDH13: Cadherin 13, H-cadherin (heart)
     evidenced by: QTL:14665;
   • CNTN5: Contactin 5
     evidenced by: QTL:154002;
   • COG2: Component of oligomeric golgi complex 2
     evidenced by: QTL:296880;
   • CYP2B6: Cytochrome P450 subfamily 2B
     evidenced by: QTL:28508;
   • EEF1A1: Eukaryotic translation elongation factor 1 alpha 1
     evidenced by: QTL:258232;
   • FABP4: Fatty acid binding protein 4, adipocyte
     evidenced by: QTL:296824; QTL:296825; QTL:296826; QTL:296827; QTL:296828; QTL:296829; QTL:296830; QTL:296831; QTL:296832; QTL:296833; QTL:296834; QTL:296835; QTL:296836; QTL:296837; QTL:296838; QTL:296839; QTL:296840; QTL:296841; QTL:296842; QTL:296843; QTL:296844; QTL:296845; QTL:296846;
   • FNDC3B: Fibronectin type III domain containing 3B
     evidenced by: QTL:14655;
   • GHR: Growth hormone receptor
     evidenced by: QTL:154016; QTL:154017; QTL:28510;
   • GNA14: G protein subunit alpha 14
     evidenced by: QTL:296820;
   • GPR137: G protein-coupled receptor 137
     evidenced by: QTL:14673;
   • HIF1AN: Hypoxia inducible factor 1 subunit alpha inhibitor
     evidenced by: QTL:296877;
   • HMCN1: Hemicentin 1
     evidenced by: QTL:154007; QTL:154008; QTL:25116; QTL:25117;
   • HSPB8: Heat shock protein family B (small) member 8
     evidenced by: QTL:296852; QTL:296853;
   • HSPBAP1: HSPB1 associated protein 1
     evidenced by: QTL:296809; QTL:296810;
   • INSIG1: Insulin induced gene 1
     evidenced by: QTL:28503;
   • IP6K3: Inositol hexakisphosphate kinase 3
     evidenced by: QTL:14669;
   • IPO11: Importin 11
     evidenced by: QTL:154015;
   • LHPP: Phospholysine phosphohistidine inorganic pyrophosphate phosphatase
     evidenced by: QTL:296878;
   • LIFR: Leukemia inhibitory factor receptor alpha
     evidenced by: QTL:28512;
   • LMCD1: LIM and cysteine rich domains 1
     evidenced by: QTL:154050;
   • LRP5: Low density lipoprotein receptor-related protein 5
     evidenced by: QTL:28516;
   • MSTN: Myostatin
     evidenced by: QTL:11875; QTL:296811; QTL:296812;
   • MYH13: Myosin heavy chain 13
     evidenced by: QTL:296858; QTL:296859; QTL:296860;
   • MYH3: Myosin, heavy chain 3, skeletal muscle, embryonic
     evidenced by: QTL:296861; QTL:296862; QTL:296863;
   • MYL6B: Myosin light chain 6B
     evidenced by: QTL:296817;
   • MYO10: Myosin X
     evidenced by: QTL:28515;
   • NDUFB8: NADH:ubiquinone oxidoreductase subunit B8
     evidenced by: QTL:296875; QTL:296876;
   • NDUFS4: NADH:ubiquinone oxidoreductase subunit S4
     evidenced by: QTL:296864;
   • NECAP2: NECAP endocytosis associated 2
     evidenced by: QTL:28502;
   • NOS1AP: Nitric oxide synthase 1 adaptor protein
     evidenced by: QTL:296814;
   • NOS2: Nitric oxide synthase 2
     evidenced by: QTL:296856; QTL:296857;
   • NOS3: Nitric oxide synthase 3
     evidenced by: QTL:296815; QTL:296816;
   • NR1I3: Nuclear receptor subfamily 1, group I, member 3
     evidenced by: QTL:37429;
   • OCLN: Occludin
     evidenced by: QTL:154013; QTL:154014; QTL:28509;
   • OSMR: Oncostatin M receptor
     evidenced by: QTL:154018; QTL:28511;
   • PARP14: Poly (ADP-ribose) polymerase family, member 14
     evidenced by: QTL:28492; QTL:296808;
   • PCCA: Propionyl CoA carboxylase, alpha polypeptide
     evidenced by: QTL:14662;
   • PCSK6: Proprotein convertase subtilisin/kexin type 6
     evidenced by: QTL:154025; QTL:154026; QTL:25121; QTL:25123;
   • PHYHIPL: Phytanoyl-CoA 2-hydroxylase interacting protein like
     evidenced by: QTL:154044; QTL:154045;
   • PKD2: Polycystic kidney disease 2 (autosomal dominant)
     evidenced by: QTL:153970; QTL:153972; QTL:153973;
   • PLEKHA7: Pleckstrin homology domain containing, family A member 7
     evidenced by: QTL:28506;
   • PPA1: Pyrophosphatase (inorganic) 1
     evidenced by: QTL:296879;
   • PPARG: Peroxisome proliferator-activated receptor gamma
     evidenced by: QTL:296867;
   • PQLC2: PQ loop repeat containing 2
     evidenced by: QTL:28501;
   • PRKG1: Protein kinase, cGMP-dependent, type I
     evidenced by: QTL:14671;
   • PRSS2: Protease, serine, 2 (trypsin 2)
     evidenced by: QTL:24258;
   • RARRES2: Retinoic acid receptor responder (tazarotene induced) 2
     evidenced by: QTL:20671;
   • RCOR2: REST corepressor 2
     evidenced by: QTL:296881; QTL:296882;
   • REEP3: Receptor accessory protein 3
     evidenced by: QTL:14672;
   • RUFY3: RUN and FYVE domain containing 3
     evidenced by: QTL:14657; QTL:14658;
   • RYR1: Ryanodine receptor 1
     evidenced by: QTL:296854; QTL:296855;
   • SDHB: Succinate dehydrogenase complex iron sulfur subunit B
     evidenced by: QTL:296813;
   • SLC45A2: Solute carrier family 45, member 2
     evidenced by: QTL:28514;
   • SMAD4: SMAD family member 4
     evidenced by: QTL:296872; QTL:296873;
   • SMAD5: SMAD family member 5
     evidenced by: QTL:296818; QTL:296819;
   • SMARCAL1: SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1
     evidenced by: QTL:153953; QTL:153954; QTL:153955; QTL:153956; QTL:153957; QTL:153959; QTL:153960; QTL:28500;
   • SMC1B: Structural maintenance of chromosomes 1B
     evidenced by: QTL:180974;
   • SORL1: Sortilin-related receptor, L(DLR class) A repeats containing
     evidenced by: QTL:25115;
   • TNFAIP2: TNF alpha induced protein 2
     evidenced by: QTL:296865; QTL:296866;
   • UBA5: Ubiquitin-like modifier activating enzyme 5
     evidenced by: QTL:28495;
   • UCP1: Uncoupling protein 1 (mitochondrial, proton carrier)
     evidenced by: QTL:296850; QTL:296851;
   • UCP2: Uncoupling protein 2 (mitochondrial, proton carrier)
     evidenced by: QTL:296848; QTL:296849;
   • UGT3A1: UDP glycosyltransferase 3 family, polypeptide A1
     evidenced by: QTL:28513;
   • UMPS: Uridine monophosphate synthetase
     evidenced by: QTL:154046; QTL:154047; QTL:28493;
   • ZBTB41: Zinc finger and BTB domain containing 41
     evidenced by: QTL:154610;
   211 correlations are found involving Residual feed intake